Cargando…

Rabies Control: Could Innovative Financing Break the Deadlock?

The neglected zoonotic diseases (NZDs) have been all but eradicated in wealthier countries but remain major causes of ill-health and mortality in over 80 countries across Africa, Asia, and Latin America. The nature of neglect for the NZDs has been ascribed, in part, to underreporting resulting in an...

Descripción completa

Detalles Bibliográficos
Autores principales: Welburn, Susan C., Coleman, Paul G., Zinsstag, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343007/
https://www.ncbi.nlm.nih.gov/pubmed/28337440
http://dx.doi.org/10.3389/fvets.2017.00032
_version_ 1782513285245960192
author Welburn, Susan C.
Coleman, Paul G.
Zinsstag, Jakob
author_facet Welburn, Susan C.
Coleman, Paul G.
Zinsstag, Jakob
author_sort Welburn, Susan C.
collection PubMed
description The neglected zoonotic diseases (NZDs) have been all but eradicated in wealthier countries but remain major causes of ill-health and mortality in over 80 countries across Africa, Asia, and Latin America. The nature of neglect for the NZDs has been ascribed, in part, to underreporting resulting in an underestimation of their global burden that, together with a lack of advocacy, downgrades their relevance to policy-makers and funding agencies. While this may be the case for many NZDs, for rabies this is not the case. The global burden estimates for rabies (931,600 DALYs) more than justify prioritizing rabies control building on the strong advocacy platforms, functioning at local, regional, and global levels (including the Global Alliance for Rabies Control), and commitments from WHO, OIE, and FAO. Simple effective tools for rabies control exist together with blueprints for operationalizing control, yet, despite elimination targets being set, no global affirmative action has been taken. Rabies control demands activities both in the short term and over a long period of time to achieve the desired cumulative gains. Despite the availability of effective vaccines and messaging tools, rabies will not be sustainably controlled in the near future without long-term financial commitment, particularly as disease incidence decreases and other health priorities take hold. While rabies control is usually perceived as a public good, public private partnerships could prove equally effective in addressing endemic rabies through harnessing social investment and demonstrating the cost-effectiveness of control. It is acknowledged that greater attention to navigating local realities in planning and implementation is essential to ensuring that rabies, and other neglected diseases, are controlled sustainably. In the shadows of resource and institutional limitations in the veterinary sector in low- and middle-income countries, sufficient funding is required so that top-down interventions for rabies can more explicitly engage with local project organization capacity and affected communities in the long term. Development Impact Bonds have the potential to secure the financing required to deliver effective rabies control.
format Online
Article
Text
id pubmed-5343007
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53430072017-03-23 Rabies Control: Could Innovative Financing Break the Deadlock? Welburn, Susan C. Coleman, Paul G. Zinsstag, Jakob Front Vet Sci Veterinary Science The neglected zoonotic diseases (NZDs) have been all but eradicated in wealthier countries but remain major causes of ill-health and mortality in over 80 countries across Africa, Asia, and Latin America. The nature of neglect for the NZDs has been ascribed, in part, to underreporting resulting in an underestimation of their global burden that, together with a lack of advocacy, downgrades their relevance to policy-makers and funding agencies. While this may be the case for many NZDs, for rabies this is not the case. The global burden estimates for rabies (931,600 DALYs) more than justify prioritizing rabies control building on the strong advocacy platforms, functioning at local, regional, and global levels (including the Global Alliance for Rabies Control), and commitments from WHO, OIE, and FAO. Simple effective tools for rabies control exist together with blueprints for operationalizing control, yet, despite elimination targets being set, no global affirmative action has been taken. Rabies control demands activities both in the short term and over a long period of time to achieve the desired cumulative gains. Despite the availability of effective vaccines and messaging tools, rabies will not be sustainably controlled in the near future without long-term financial commitment, particularly as disease incidence decreases and other health priorities take hold. While rabies control is usually perceived as a public good, public private partnerships could prove equally effective in addressing endemic rabies through harnessing social investment and demonstrating the cost-effectiveness of control. It is acknowledged that greater attention to navigating local realities in planning and implementation is essential to ensuring that rabies, and other neglected diseases, are controlled sustainably. In the shadows of resource and institutional limitations in the veterinary sector in low- and middle-income countries, sufficient funding is required so that top-down interventions for rabies can more explicitly engage with local project organization capacity and affected communities in the long term. Development Impact Bonds have the potential to secure the financing required to deliver effective rabies control. Frontiers Media S.A. 2017-03-09 /pmc/articles/PMC5343007/ /pubmed/28337440 http://dx.doi.org/10.3389/fvets.2017.00032 Text en Copyright © 2017 Welburn, Coleman and Zinsstag. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Welburn, Susan C.
Coleman, Paul G.
Zinsstag, Jakob
Rabies Control: Could Innovative Financing Break the Deadlock?
title Rabies Control: Could Innovative Financing Break the Deadlock?
title_full Rabies Control: Could Innovative Financing Break the Deadlock?
title_fullStr Rabies Control: Could Innovative Financing Break the Deadlock?
title_full_unstemmed Rabies Control: Could Innovative Financing Break the Deadlock?
title_short Rabies Control: Could Innovative Financing Break the Deadlock?
title_sort rabies control: could innovative financing break the deadlock?
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343007/
https://www.ncbi.nlm.nih.gov/pubmed/28337440
http://dx.doi.org/10.3389/fvets.2017.00032
work_keys_str_mv AT welburnsusanc rabiescontrolcouldinnovativefinancingbreakthedeadlock
AT colemanpaulg rabiescontrolcouldinnovativefinancingbreakthedeadlock
AT zinsstagjakob rabiescontrolcouldinnovativefinancingbreakthedeadlock